NXL (nexalin.com) Quarterly EPS earnings growth

Brandmark of Nexalin Technology Inc (NXL)

The implementation of ESG standards and bioethics into the production of neurostimulators by Nexalin Technology, Inc. (NXL) correlates with the history of quarterly earnings per share changes, where the metric value stands at 10.80. The financial potential is based on an unrivaled non-drug method for treating depression. However, the company's future profitability relies on obtaining FDA approval and insurance reimbursement codes to establish market pricing power.

Nexalin Technology Inc (NXL) Year-over-year earnings per share growth for the last 12 months: for the period 04/28/2023 - 11/15/2026

nexalin.com - analytical breakdowns and key metrics (NXL)

- market value and analyst target forecast:
Price Chart Nexalin Technology Inc|NXL - Price Target Chart
- business market valuation indicators:
Market Capitalization Nexalin Technology Inc|NXL - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Nexalin Technology|NXL - Accounting Capitalization|Market Cap to Net Assets Ratio nexalin.com|NXL - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Equity Ratio Nexalin Technology, Inc.|NXL - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital nexalin.com|NXL - Company Cumulative Debt|Debts to Book Capitalization Nexalin Technology, Inc.|NXL - Company Long-Term Liabilities|Company Short-Term Debts Nexalin Technology|Quick Liquidity nexalin.com
- earnings and market multiples details:
NXL - Company Profit|Expected Profit Nexalin Technology, Inc.|NXL - Market Cap to Earnings|Future Price to Earnings Nexalin Technology Inc|NXL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nexalin|NXL - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Nexalin Technology|NXL - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months nexalin.com|NXL - Earnings per share growth rate in current year|Expected earnings per share growth for next year Nexalin Technology, Inc.
- company sales and revenue statistics:
NXL - Company Sales Revenue|Projected Sales Volume Nexalin Technology, Inc.|NXL - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Nexalin Technology Inc|NXL - Sales Growth YoY (Last 12 Months)
Comprehensive company analysis:nexalin.com - NXL
Finished products of Nexalin Technology, Inc.

The stability of Nexalin Technology, Inc. (NXL) is driven by the commercialization of non-invasive brain stimulators that replace pharmacological treatments for depression. By analyzing the growth rates of quarterly net earnings per share, investors assess real earnings dynamics amid external shocks, where an upward trend confirms business scaling and deviations signal asset overheating, allowing for an adjustment of its fair value.

Main competitors

ACHC: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LifeStance Corp (LFST)|Year-over-year earnings per share growth for the last twelve months BrainsWay